InvestorsHub Logo
icon url

Brian903

11/18/20 9:10 AM

#49264 RE: zugisland #49263

Agree, Illumina knows this as well and is buying GRAIL back at a substantial price.

https://www.biopharmadive.com/news/illumina-buy-grail-cancer-screening/585606/

Illumina has agreed to acquire Grail in an $8 billion deal that could establish the sequencing giant as a leading player in the growing race to use blood-based tests known as liquid biopsies to catch cancers early.